Cynosure, Inc. (NASDAQ: CYNO) today announced that it has received a medical device license issued by Health Canada to market MonaLisa Touch ® for the treatment of symptoms related to Genitourinary ...
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www ...
Cynosure, Inc. (NASDAQ: CYNO) a leader in laser- and light-based aesthetic treatments, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ...
Seasoned med-tech executive to advance Cynosure's growth and innovation strategy and strengthen the company's position as the medical aesthetics technology leader WESTFORD, Mass., April 24, 2023 ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today that it has entered into a definitive agreement to sell its Cynosure medical aesthetics business to an affiliate of ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that it has entered into a definitive agreement to sell its Cynosure medical aesthetics business to an affiliate of ...
Seasoned med-tech executive to advance Cynosure’s growth and innovation strategy and strengthen the company’s position as the medical aesthetics technology leader Cynosure, LLC (“Cynosure” or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback